NCT05866887View on ClinicalTrials.gov

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 26, 2023

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
Pediatric Acute Lymphoblastic LeukemiaLeukemiaAcute Lymphoblastic Leukemia
Interventions
BEHAVIORAL

Sleep ALL Night

Sleep intervention program comprised of a sleep action plan tool and interactive psychoeducation website.

Trial Locations (2)

02215

Boston Children's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT05866887 - Insomnia Prevention in Children With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter